ImageneBio, Inc. (IMA) stock

IMANasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 9, 2026Score 7/30

$3.47+0.02 (+0.58%)

Close on Nov 13, 2026Market cap $39.39MP/E –Yield –

ImageneBio pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

ImageneBio has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is IMA.

Advertisement
300 × 250

See a number that looks wrong?